LALPATHLAB - IntraDay Trade Analysis with Live Signals

Last Updated Time : 20 Dec 25, 07:02 am

IntraDay Trade Rating: 3.0

📊 Analysis: LALPATHLAB is trading at ₹1,394, below both 50 DMA (₹1,522) and 200 DMA (₹1,510), reflecting short-term weakness. RSI at 26.2 indicates oversold conditions, while MACD (-40.6) confirms bearish momentum. Intraday volume (2.42 Lakh) is above average (1.98 Lakh), suggesting active participation. The stock is closer to its 52-week low (₹1,147) than its high (₹1,771), showing pressure but potential for short-term bounce trades.

• 💡 Optimal Buy Price: ₹1,385–₹1,400 range if support near ₹1,370 holds.
• 📈 Profit-Taking Exit Levels: ₹1,420 (minor resistance), ₹1,450–₹1,480 (short-term resistance zone).
• ⚠️ Stop-Loss / Loss Protection: ₹1,370 (below intraday support).
• ⏱️ If Already Holding: Consider exiting near ₹1,420–₹1,480 if momentum stalls; cut positions if price breaks below ₹1,370 with rising volume.

Positive

• 📌 Strong ROCE (30.6%) and ROE (24.7%) — efficient capital use.
• 📌 EPS at ₹31.6 indicates solid earnings base.
• 📌 PAT growth from ₹129 Cr. to ₹146 Cr. (+13.1% QoQ).
• 📌 DII holding increased by 0.60% — domestic institutions showing confidence.
• 📌 Debt-to-equity ratio at 0.06 — low leverage.

Limitation

• ⚠️ Current price below both 50 DMA and 200 DMA — weak technical setup.
• ⚠️ RSI oversold but MACD bearish — momentum conflict.
• ⚠️ High P/E (44.2 vs industry 30.9) — premium valuation.
• ⚠️ PEG ratio (3.35) indicates growth concerns relative to valuation.

Company Negative News

• ❌ Stock trading far below DMA levels, showing short-term weakness.
• ❌ FII holding decreased by -0.17% — foreign investor sentiment weakening.

Company Positive News

• ✅ Strong quarterly profit growth (+13.1%).
• ✅ EPS and ROCE/ROE support fundamentals.
• ✅ DII confidence reflected in increased holdings.

Industry

• 🏦 Industry P/E at 30.9 — sector moderately valued.
• 🏦 LALPATHLAB trades at a premium (P/E 44.2), reflecting brand strength but valuation risk.

Conclusion

⚖️ LALPATHLAB is a weak-to-moderate intraday candidate today due to oversold RSI and bearish MACD. Traders may attempt cautious entries near ₹1,385–₹1,400 with stop-loss at ₹1,370 and aim for exits between ₹1,420–₹1,480. Elevated volume offers trading opportunity, but overall risk-reward is limited, making it suitable only for defensive scalps rather than aggressive intraday trades.

Would you like me to extend this into a diagnostics & healthcare sector basket overlay so you can benchmark LALPATHLAB against peers like Metropolis, Dr. Lal’s competitors, and Thyrocare for intraday rotation setups?